Michael S Kelly (Michael Kelly)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Ankylosing Spondylitis

Systematic Review

Cardiovascular Events

Systemic Sclerosis

Top Venues

Pharmacotherapy

Pharmacy (Basel, Switzerland)

Diabetes, obesity & metabolism

Journal of cardiovascular pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael S Kelly, Emily M Scopelliti, Kaylee E Goodson, Ching Mann Anne Lo, Huelena X Nguyen, Barbara Simon
Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism (2024)
Ibrahim S Alhomoud, Azita Talasaz, Anurag Mehta, Michael S Kelly, Evan M Sisson, Audrieanna Browning, Roy Brown, Dave L Dixon
Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease: A Review of Current and Emerging Therapies. Pharmacotherapy (2023)
Michael S Kelly, Ana Dacey, Audrey Siana, Jason Ojeda
Efficacy and Safety of a polypill to reduce cardiovascular events: A review of clinical trials. Journal of cardiovascular pharmacology (2023)
Michael S Kelly, Jelena Lewis, Hindu Rao, Jessica Carter, Ivan Portillo, Richard Beuttler
Effects of GLP-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta-analysis. Pharmacotherapy (2022)
Mary Elkomos, Raha Jahromi, Michael S Kelly
Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature. Pharmacy (Basel, Switzerland) 10 (1) (2022)